| 1. |
Kimura Y, Shinoda M, Shinkai M, Kaneko T: Solithromycin inhibits IL-13-induced goblet cell hyperplasia and MUC5AC, CLCA1, and ANO1 in human bronchial epithelial cells. PeerJ, 11: e14695, 2023. |
| 2. |
Sakurai Y, Oshikata C, Katayama T, Takagi S, Kaneko Y, Yo K, Kaneko T, Kubota H, Matsubara T, Tsurikisawa N: A case of eosinophilic polyangiitis with granulomatosis that evolved to cardiac arrest due to advanced atrioventricular block. Nagoya J Med Sci, 85: 171-178, 2023. |
| 3. |
Fujii H, Hara Y, Saigusa Y, Tagami Y, Murohashi K, Nagasawa R, Aoki A, Izawa A, Seki K, Watanabe K, Horita N, Kobayashi N, Kaneko T: ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease. Can Respir J, 2023: 5088207, 2023. |
| 4. |
Nagasawa R, Hara Y, Murohashi K, Saigusa Y, Nishikawa Y, Tanaka M, Aoki A, Tagami Y, Kobayashi N, Kudo M, Kaneko T: Additional Efficacy of Macrolide for Patients With Acute Deterioration of Interstitial Lung Disease Requiring Corticosteroid Pulse Therapy. Am J Ther, 30: 170-173, 2023. |
| 5. |
Honda Y, Yoneda M, Kobayashi T, Iwaki M, Kawamura N, Nogami A, Kessoku T, Ogawa Y, Tomeno W, Imajo K, Horita N, Saito S, Kaneko T, Nakajima A: Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease. Hepatol Res, 53: 219-227, 2023. |
| 6. |
Takayasu H, Kata Y, Otsu Y, Inoue S, Kaneko T: ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report. Cureus, 15: e36711, 2023. |
| 7. |
Watanabe K, Kobayashi N, Kaneko T: Recurrent Transient Asymptomatic Pulmonary Opacity with Long-Term Afatinib: A Case Report. Case Rep Oncol, 16: 167-171, 2023. |
| 8. |
Matsumoto H, Kobayashi N, Shinoda S, Goto A, Kaneko A, Fukuda N, Kamimaki C, Kubo S, Watanabe K, Horita N, Hara Y, Ishikawa Y, Kaneko T: Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan. Sci Rep, 13: 5208, 2023. |
| 9. |
Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T: Clinical features of asthma with connective tissue diseases. Clin Respir J, 17: 303-310, 2023. |
| 10. |
Hiro S, Teranishi S, Sawazumi T, Nagaoka S, Sugimoto C, Nagayama H, Segawa W, Kajita Y, Maeda C, Kubo S, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report. Thorac Cancer, 14: 1311-1315, 2023. |
| 11. |
Sugimoto C, Teranishi S, Sawazumi T, Nagaoka S, Nagayama H, Segawa W, Hiro S, Kajita Y, Maeda C, Kubo S, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Primary tracheal small-cell carcinoma detected 11 months after surgery for pulmonary large-cell neuroendocrine carcinoma: A case report. Thorac Cancer, 14: 1212-1216, 2023. |
| 12. |
Masumoto N, Oshikata C, Nakadegawa R, Motobayashi Y, Osada R, Manabe S, Kaneko T, Tsurikisawa N: Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis. Allergy Asthma Clin Immunol, 19: 40, 2023. |
| 13. |
Fukuda N, Horita N, Kaneko A, Goto A, Kaneko T, Ota E, Kew KM: Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 6: CD012066, 2023. |
| 14. |
Kata Y, Hara Y, Murohashi K, Saigusa Y, Nagasawa R, Tagami Y, Fujii H, Aoki A, Nishikawa Y, Tanaka K, Watanabe K, Horita N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: ＜Editors' Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia. Nagoya J Med Sci, 85: 302-611, 2023. |
| 15. |
Chen H, Yumoto K, Kashizaki F, Koizumi H, Ikeda I, Horita N, Takahashi K, Kaneko T: KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer. Transl Lung Cancer Res, 12: 1830-1833, 2023. |
| 16. |
Hirama N, Yamamoto M, Nagaoka S, Segawa W, Sugimoto C, Nagayama H, Hiro S, Kajita Y, Maeda C, Kubo S, Seki K, Nagahara Y, Teranishi S, Tashiro K, Hara Y, Kobayashi N, Watanabe S, Kudo M, Kaneko T: Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma. Thorac Cancer, 14: 2601-2607, 2023. |
| 17. |
Hamakawa Y, Agemi Y, Shiba A, Ikeda T, Higashi Y, Aga M, Miyazaki K, Taniguchi Y, Misumi Y, Nakamura Y, Shimokawa T, Saigusa Y, Kobayashi N, Okamoto H, Kaneko T: Association of PD-L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC. Cancer Med, 12: 17788-17797, 2023. |
| 18. |
Matsumoto H, Somekawa K, Horita N, Ueda S, Kaneko M, Kaneko A, Fukuda N, Izawa A, Kamimaki C, Tanaka K, Murohashi K, Fuji H, Tagami Y, Aoki A, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis. Ther Adv Med Oncol, 15: 17588359231198453, 2023. |
| 19. |
Aoki A, Hara Y, Fujii H, Murohashi K, Nagasawa R, Tagami Y, Enomoto T, Matsumoto Y, Masuda M, Watanabe K, Horita N, Kobayashi N, Kudo M, Ogura T, Kaneko T: The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study. PLoS One, 18: e0291489, 2023. |
| 20. |
Masumoto N, Kato S, Aichi M, Hasegawa S, Sahara K, Suyama K, Sano A, Miyazaki T, Okudela K, Kaneko T, Takahashi T: AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines. Thorac Cancer, 14: 2897-2908, 2023. |
| 21. |
Kajita Y, Teranishi S, Sawazumi T, Watanabe H, Nagaoka S, Tanaka A, Suzukawa Y, Motobayashi Y, Hirose T, Maeda C, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Inayama Y, Kaneko T: Comparison of the slow-pull and aspiration methods of endobronchial ultrasound-guided transbronchial needle aspiration for next-generation sequencing-compatible tissue collection in non-small cell lung cancer. Cancer Med, 12: 19512-19522, 2023. |
| 22. |
Nakamura K, Fujita Y, Chen H, Somekawa K, Kashizaki F, Koizumi H, Takahashi K, Horita N, Hara Y, Muro S, Kaneko T: The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis. Diseases, 11: 152, 2023. |
| 23. |
Kobayashi N, Miura K, Kaneko A, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Kudo M, Miyazawa N, Kaneko T: Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes. Cancers (Basel), 15: 5248, 2023. |
| 24. |
Nagasawa R, Niwa T, Hagiwara E, Oda T, Yamada S, Okuda R, Baba T, Komatsu S, Kaneko T, Ogura T: Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19. Intern Med, 62: 3125-3130, 2023. |
| 25. |
Inoue S, Kata Y, Suido Y, Nakashima K, Otsu Y, Takayasu H, Matsumoto Y, Kaneko T: Limited efficacy of low-dose dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective study. Respir Investig, 61: 760-767, 2023. |
| 26. |
Masumoto N, Oshikata C, Nakadegawa R, Motobayashi Y, Osada R, Manabe S, Kaneko T, Tsurikisawa N: Dupilumab suppresses relapsing chronic eosinophilic pneumonia with severe asthma. Nagoya J Med Sci, 85: 857-865, 2023. |
| 27. |
Tagami Y, Horita N, Kaneko M, Muraoka S, Fukuda N, Izawa A, Kaneko A, Somekawa K, Kamimaki C, Matsumoto H, Tanaka K, Murohashi K, Aoki A, Fujii H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Whole-genome sequencing predicting phenotypic antitubercular drug resistance: meta-analysis. J Infect Dis, 2023. [Epub ahead of print] |
| 28. |
Chen H, Kondo M, Horita N, Takahashi K, Kaneko T: The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment. Cancers (Basel), 15: 5346, 2023. |
| 29. |
Tanaka M, Oshikata C, Yamashita Y, Isono R, Nakadegawa R, Masumitsu H, Motobayashi Y, Osada R, Takayasu H, Masumoto N, Manabe S, Kaneko T, Ueno A, Tsurikisawa N: Eosinophilic granulomatosis with polyangiitis and severe cardiac involvement in a patient surviving for 34 years. J Asthma, 60: 2233-2242, 2023. |
| 30. |
Kubo S, Kobayashi N, Matsumoto H, Somekawa K, Kaneko A, Hashimoto H, Teranishi S, Watanabe K, Horita N, Hara Y, Kudo M, Kaneko T: Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer. J Cancer Res Clin Oncol, 149: 17419-17426, 2023. |
| 31. |
Tagami Y, Hara Y, Murohashi K, Nagasawa R, Fujii H, Izawa A, Yabe A, Saigusa Y, Kobayashi M, Shiida M, Hirata M, Otsu Y, Watanabe K, Horita N, Kobayashi N, Kaneko T: Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease. Sci Rep, 13: 22639, 2023. |
| 32. |
Watanabe K, Koji O, Matsumura M, Kaneko T: Post-COVID-19 Granulomatous Inflammation in the Lung, Distinct From Sarcoidosis: A Report of Two Cases. Cureus, 15: e50821, 2023. |
Copyright(C) 横浜市立大学大学院医学研究科呼吸器病学 All Rights Reserved.